The C/EBP family of transcription factors is associated with mesenchymal gene signatures and aggressive diseases in a variety of tumors including glioblastomas [48,49,50], esophageal squamous cell carcinoma [51], urothelial carcinoma [52], and hepatocellular carcinoma [53]. This evidence concerns the gene CEBPA and glioblastoma.